Draft Pharma Policy 2025 of Odisha encourages ease of doing businesses: Peethaambaran Kunnathoor, Chennai Wednesday, February 12, 2025, 08:00 Hrs [IST] Following the ‘Make-in-Od ...
Antimicrobial resistance (AMR) presents a significant challenge to global health, necessitating innovative therapeutic ...
These drugs, discovered decades ago, continue to save lives today, but more recent research has led to the development of ...
Therefore, moving away from the problems that plant-based biofuels can cause ... reduced costs for food or drug production, and reduced need for pesticides. Biotech giant Bayer is one of the leading ...
Innovation, a right to health, and rare disease research – biotechnical drugs for such are what the future is being built on, he said. Already, the effects of the Biotech Centre of Excellence ...
A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...
A Hong Kong biotech start-up is working with a number of university partners to conduct global clinical trials that could lead to a better way of delivering drugs for prevalent eye diseases.
Two biotechs say they’re using AI to conjure drugs from scratch. Their documents suggest otherwise
A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
Boehringer Ingelheim has cemented the potential of its idiopathic pulmonary fibrosis (IPF) drug with a second phase 3 win in a related lung disease leading the drugmaker to expand the indications ...
Story Feb. 11 - Inventiva: Low on cash, the French biotech told its workers council that it will be halving its head count as it focuses exclusively on investigational MASH drug lanifibranor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback